Age, Biography and Wiki

Guadalupe Sabio was born on 4 June, 1977 in Badajoz. Discover Guadalupe Sabio's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is She in this year and how She spends money? Also learn how She earned most of networth at the age of 43 years old?

Popular As N/A
Occupation N/A
Age 44 years old
Zodiac Sign Gemini
Born 4 June 1977
Birthday 4 June
Birthplace Badajoz
Nationality Spanish

We recommend you to check the complete list of Famous People born on 4 June. She is a member of famous with the age 44 years old group.

Guadalupe Sabio Height, Weight & Measurements

At 44 years old, Guadalupe Sabio height not available right now. We will update Guadalupe Sabio's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.

Parents Not Available
Husband Not Available
Sibling Not Available
Children Not Available

Guadalupe Sabio Net Worth

Her net worth has been growing significantly in 2020-2021. So, how much is Guadalupe Sabio worth at the age of 44 years old? Guadalupe Sabio’s income source is mostly from being a successful . She is from Spanish. We have estimated Guadalupe Sabio's net worth, money, salary, income, and assets.

Net Worth in 2021 $1 Million - $5 Million
Salary in 2020 Under Review
Net Worth in 2019 Pending
Salary in 2019 Under Review
House Not Available
Cars Not Available
Source of Income

Guadalupe Sabio Social Network

Twitter Guadalupe Sabio Twitter
Wikipedia Guadalupe Sabio Wikipedia



She believes that obesity will be a major challenge for future generations, and it should be taken as seriously as smoking. By considering fat, adipose tissue, as an endocrine organ she believes people will think more carefully about how to care for it. She believes that the best antidotes to obesity are exercise and diet. In 2017 Sabio was inducted into the European Molecular Biology Organization.


Sabio joined the Spanish National Cardiovascular Research Centre in 2011. Sabio is investigating the molecular mechanisms that are associated with obesity, and how they can predispose patients to other conditions such as hepatocellular carcinoma. Hepatocellular carcinoma is a type of liver carcinoma, and the second most common cause of cancer-related deaths. Whilst there is chemotherapy available, it can only increase a patient's life by three months. Sabio researches p38gamma, a kinase protein that is expressed excessively in patients with hepatocellular carcinoma, and whether inhibition of this protein could reduce the cancer. She is developing drugs that inhibit p38gamma for the treatment of liver cancer. She has also investigated the C-Jun N-terminal kinases (JNK) protein, which is known to control obesity.


Guadalupe Sabio Buzo (born 4 June, 1977) is a Spanish scientist and Professor at the Spanish National Cardiovascular Research Centre, which is part of the Carlos III Health Institute. Her research considers stress-activated kinases and the development of diseases associated with obesity. She was awarded the Princess of Girona Foundation Scientist Prize in 2012 and selected as one of the Top 100 Women Leaders in Spain in 2017.

Sabio was born in Badajoz in 1977. She attended the Colegio del Santo Ángel and the Institute of San Fernando. She studied veterinary sciences at the University of Extremadura, and graduated in 2000 with an extraordinary award. She has said that she chose to study veterinary science as she liked animals very much, and that this could help her understand the origins of diseases. She moved to the United Kingdom for her doctoral studies, where she joined the University of Dundee as an Medical Research Council European graduate student. She completed her doctorate on p38 delta kinases in 2005. Whilst her PhD had taught her how to research in vitro, Sabio was keen to translate her research into mouse models. She joined the research group of Roger Davis at the Howard Hughes Medical Institute where she studied the impact of stress on kinases proteins. In 2009 she was awarded Santiago Ramón y Cajal funding to join a biotechnology laboratory in Spain.